Marek Mráz
- Genetics top 1%
- Chronic Lymphocytic Leukemia Research 28
- Cancer Research top 2%
- MicroRNA in disease regulation 11
- Immunology top 5%
- Immune Cell Function and Interaction 7
- Galectins and Cancer Biology 7
- Immunodeficiency and Autoimmune Disorders 6
-
- Lymphoma Diagnosis and Treatment 14
- Molecular Biology top 10%
- Pluripotent Stem Cells Research 3
-
- Cancer-related Molecular Pathways 5
- Co-authors
- Šárka Pospı́šilováGabriela Mladonická PavlasováJiřı́ MayerVáclav ŠedaKarla MalinováBranislav KusendaMichael DoubekThomas J. Kipps
- Cited by
- GeneticsCancer ResearchImmunology
- Partner nations
- CzechiaUnited StatesAustria
In The Last Decade
Marek Mráz
48 papers receiving 2.4k citations
Hit Papers
Peers
Comparison fields: 5 of 111
- Genetics 702
- Cancer Research 917
- Immunology 650
- Pathology and Forensic Medicine 551
- Molecular Biology 1.2k
Countries citing papers authored by Marek Mráz
This map shows the geographic impact of Marek Mráz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marek Mráz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marek Mráz more than expected).
Fields of papers citing papers by Marek Mráz
This network shows the impact of papers produced by Marek Mráz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marek Mráz. The network helps show where Marek Mráz may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Marek Mráz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2024 | 9 | |
| 3 | 2023 | 4 | |
| 4 | 2022 | 10 | |
| 5 | 2020 | 56 | |
| 6 | 2019 | 13 | |
| 7 | 2019 | 22 | |
| 8 | 2018 | 34 | |
| 9 | 2018 | 42 | |
| 10 | 2018 | 20 | |
| 11 | 2014 | 106 | |
| 12 | 2013 | 26 | |
| 13 | 2013 | 1 | |
| 14 | 2013 | 46 | |
| 15 | 2012 | 6 | |
| 16 | 2009 | 176 | |
| 17 | 2009 | 86 | |
| 18 | 2006 | 129 | |
| 19 | 1991 | 34 | |
| 20 | 1991 | 3 |
About Marek Mráz
Marek Mráz is a scholar working on Genetics, Immunology, Pathology and Forensic Medicine, Cancer Research and Oncology, having authored 48 papers that have together received 2.4k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (28 papers), Lymphoma Diagnosis and Treatment (14 papers), MicroRNA in disease regulation (11 papers), Immune Cell Function and Interaction (7 papers), Galectins and Cancer Biology (7 papers), Immunodeficiency and Autoimmune Disorders (6 papers), Cancer-related Molecular Pathways (5 papers) and Pluripotent Stem Cells Research (3 papers). The work is most often cited by research in Genetics (702 citations), Cancer Research (917 citations), Immunology (650 citations), Pathology and Forensic Medicine (551 citations) and Molecular Biology (1.2k citations). Marek Mráz has collaborated with scholars based in Czechia, United States and Austria. Frequent co-authors include Šárka Pospı́šilová, Gabriela Mladonická Pavlasová, Jiřı́ Mayer, Václav Šeda, Karla Malinová, Branislav Kusenda, Michael Doubek, Thomas J. Kipps, Martin Trbušek and Yvona Brychtová. Their work appears in journals such as Blood, Leukemia, Haematologica, Leukemia Research and Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.